You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

You’ve been redirected to the new Cancer Care Ontario website. You can also visit the archived website, which is no longer being maintained.

The Use of Cabazitaxel in Men with Castrate Resistant Metastatic Prostate Cancer Previously Treated with Docetaxel

ID: CED 23 Oct 2011
Type of Content: Guidelines & Advice, Clinical
Document Status: Archived
Authors:
S. Hotte, A. Haynes, N. Fleshner, A. Loblaw